Oncology Breakthroughs: How Cancer Research Is Advancing in 2025

Core Insights - The global cancer therapy market is projected to grow at a CAGR of 9.12%, reaching an estimated value of $285.96 billion by 2030 [2] - Oncolytics Biotech Inc. is advancing its innovative immunotherapy, pelareorep, which aims to convert "cold" tumors into "hot" tumors, enhancing treatment efficacy [3][4] - Recent data from Oncolytics' GOBLET study shows promising results in treating relapsed anal cancer and pancreatic cancer, with significant response rates compared to historical controls [5][6][7] Company Developments - Oncolytics Biotech has received regulatory approval to advance pelareorep in combination with mFOLFIRINOX for newly diagnosed pancreatic adenocarcinoma patients [4] - In the GOBLET study, pelareorep demonstrated a 62% objective response rate when combined with other therapies, significantly higher than the historical average of 25% [7][8] - The company is preparing for potential pivotal studies as evidence continues to support pelareorep as a transformative treatment option for patients [9] Industry Trends - There is a growing concern among experts regarding the rising rates of lung and colorectal cancers, particularly among younger populations and never-smokers [1] - The EU is reportedly lagging behind the USA in oncology innovation, highlighting a potential area for growth and investment in the sector [1] - The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care (CITEC) has launched initiatives to improve cancer detection technologies globally [2]